Intellectual Property

Patent rights in the U.S., Europe, Japan, Australia, Canada, Singapore, China, India, Hong Kong and Brazil
• 33 issued patents
• 24 pending applications

Patent portfolio of (7) patent families including:
• BPZE strains
• BPZE vaccines for the prevention of Whooping Cough
• Influenza Cross-protection
• Asthma and Allergy treatment/prophylaxis
• New BPZE1 strains

Country

Name

Patent No.

Date Issued

U.S.

• Prevention of Pertussis using Adenylate Cyclase Deficient Bordetella Strains

10,046,044 B2

Aug 14, 2018

Australia

• Novel recombinant Bordetella strains

2013333928

Mar 15, 2018

U.S.

• Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology

9,839,683 B2

Dec 12, 2017

Singapore

• Effect of an attenuated Bordetella strain against allergic disease

10201607233T

Nov 21, 2017

Hong Kong

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

09104000

Jul 21, 2017

U.S.

• Attenuated Bordetella strains

9,730,995

Aug 15, 2017

Australia

• Effect of an attenuated Bordetella strain against allergic disease

2012331646

Jul 13, 2017

U.S.

• Adenylate cyclase deficient bordetella strains

9,655,959

May 23, 2017

U.S.

• Influenza vaccine, composition, and methods of use

9,526,778

Dec 27, 2016

U.S.

• Recombinant Bordetella Strains

9,528,086

Dec 27, 2016

Canada

• Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology

2,759,280

Sept 20, 2016

Japan

• Influenza Vaccine, Composition, And Methods of Use

5995329

Sept 2, 2016

U.S.

• Effect of an Attenuated Bordetella Strain Against Allergic Disease

9,415,077

Aug 16, 2016

Austrailia

• Influenza vaccine, composition, and methods of use

2009348207

Jul 14, 2016

Europe

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

1994139

Jul 13, 2016

Singapore

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

175803

Jun 16, 2016.

India

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

270798

Jan 20, 2016

China

• Influenza vaccine, composition, and methods of use

ZL2009801609531

Nov 25, 2015

U.S.

• Method of using attenuated Bordetella strains

9,180,178

Nov 10, 2015

U.S.

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

9,119,804

Sept 1, 2015

Europe

• Influenza vaccine, composition, and methods of use

2442826

Jul 8, 2015

Canada

• Influenza vaccine, composition, and methods of use

2,765,364

May 26, 2015

China

• Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology

ZL 2010 8 0019636.0

May 13, 2015

U.S.

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

8,986,709

Mar 24, 2015

Europe

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2424564

Feb 25, 2015

Japan

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

5678034

Jan 1, 2015

Australia

• Vaccine for prophylaxis or treatment of an allergen-driven airway pathology

2010243708

Sept 25, 2014

Australia

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

2007224734

May 16, 2013

Japan

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

5551774

Apr 19, 2013

Japan

• Influenza vaccine, composition, and methods of use

2013-524092

Apr 4, 2013

China

• Live attenuated Bordetella strains as a single dose vaccine against whooping cough

ZI2007800085686

Mar 20, 2013

France

• Strains of Bordetella made deficient by means of genetic attenuation

2840319

Aug 20, 2004


Copyright 2013-2018 ILiAD Biotechnologies